To assist scientists and clinicians working at the forefront of cancer research, the Basser Center for BRCA provides grant funding opportunities for researchers working on BRCA1 and BRCA2-related projects and awards an annual global prize honoring highly influential in the field. These funding opportunities are unique in that they are available for both research conducted at the University of Pennsylvania and externally to investigators at other institutions. The Basser Center is also home to a yearly scientific symposium, held every spring, and a monthly seminar series led by prominent local researchers.
Basser Scientific Symposium
“BRCA1, BRCA2 and Beyond: An Update on Hereditary Cancer” is the Basser Center’s annual scientific symposium that began in 2013 and is held every May in Philadelphia. The event features scientists and clinical experts from around the world and focuses on recent and ongoing advances in research and clinical management of BRCA carriers. In addition to a series of presentations from leading scientists, the winner of the year’s Basser Global Prize delivers the keynote address.
A key function of the Basser Center is to provide grant funding to investigators dedicated to making progress with projects relevant to BRCA1 and BRCA2 mutations ranging from basic science and translational research to clinical trials meant to enhance the well-being and care of those living with BRCA1/2 gene mutations. These grants fund both internal research conducted by scientists at the University of Pennsylvania and innovative external proposals, with an emphasis on collaborative projects, and typically apply to topics like prevention, early detection, and therapeutics.
Basser Global Prize
Established and endowed by Shari Basser Potter and Len Potter, the Basser Global Prize honors and provides $100,000 in support to a visionary scientist conducting innovative BRCA1/2-related research that has resulted in improvements in clinical care. The annual winner is selected from a pool of researchers worldwide and presents the keynote address at the Basser Scientific Symposium.
Pearl and Philip Basser Innovation Research Award
The Pearl and Philip Basser Innovation Research Award has been established to honor an early career investigator conducting innovative BRCA-related research at the University of Pennsylvania. Candidates will be considered from across a variety of disciplines including basic, translational and clinical researchers. The award provides the recipient with a $40,000 one year, unrestricted research grant. Nominees can be at the level of Instructor through Assistant Professor. Recipients can only receive the award once.
The Application Process
The Basser Center is now accepting nominations for the award with submissions due by February 26, 2021 at 5 pm. Nominations are reviewed by the Basser Center’s Leadership Committee and members of the Center’s Internal Advisory Board. Recipients are notified by email in late March with the award announced during the Basser Center’s Annual Scientific Symposium (virtual) on May 11-12, 2021.
Candidates for the award include early career investigators involved in BRCA-related research. Candidates are to be nominated by senior faculty members from various departments at the University of Pennsylvania.
- Pearl and Philip Basser Innovation Research nomination form
- Nominating letter introducing the candidate and including a description of the nominee's applicable BRCA-related research warranting consideration for the award
- Nominee’s CV
Nomination packages should include all items saved into one PDF document submitted to the Basser Center for BRCA at firstname.lastname@example.org.
Monthly Seminar Series
The Basser Center holds a monthly seminar series presented by Penn investigators, as well as occasional speakers from other institutions, on a wide range of BRCA1/2-related topics. Held at noon on the first Friday of the month in the Smilow Translational Research Center, these seminars explore everything from advances in basic science to screening and treatment methods, hot topics in cancer research, gene sequencing, legal issues, and national healthcare concerns.*
- February 5: Donita C. Brady, PhD on "Copper Conducted Kinase Signal Transduction: A Novel Vulnerability in BRAF Mutation-Positive Melanoma and Beyond"
- March 5: Irfan Asangani, PhD
* This internal series is open to Penn faculty and staff. Seminars will be conducted virtually on Blue Jeans, details to follow.
To further the possibilities among researchers, the Basser Center has made available an inventory of cell lines, reagents, and data for use by Penn investigators. Materials and data can be requested using your Pennkey and password.